GMCH STORIES

Landmark Treatment for Lymphoma Cancer Patient in Rajasthan

( Read 2743 Times)

24 Jan 24
Share |
Print This Page
 Landmark Treatment for Lymphoma Cancer Patient in Rajasthan

*Udaipur:* In a groundbreaking medical achievement, a patient suffering from lymphoma cancer in Udaipur, Rajasthan, underwent treatment with the drug Polivy, marking the first instance of its kind in the state. The medical intervention was carried out by specialists at Paras Health, Udaipur, without the need for any surgical procedures.

Dr. Manoj Mahajan, the Director of Medical Oncology at Paras Health, led the medical team that utilized Polivy medication to effectively treat the life-threatening blood cancer known as lymphoma. Lymphoma is a type of blood cancer that poses significant challenges for treatment, often requiring methods such as chemotherapy and immunotherapy. However, the use of Polivy represents a novel approach in tackling this formidable disease.

Dr. Manoj Mahajan explained that the patient's condition was critical, necessitating frequent blood transfusions due to the blood cancer. Given the severity of the illness, a cautious and innovative treatment approach was required. The decision to use Polivy, a medication not commonly employed for lymphoma treatment, was made to eliminate the cancer cells thoroughly.

The patient's treatment involved a combination of Polivy and other medications, and the process is still ongoing with no reported side effects. The patient, who had initially lost hope of recovery, shared that it was a family friend who recommended seeking treatment at Paras Health, Udaipur. After consultation with Dr. Manoj Mahajan, the treatment commenced, providing a glimmer of hope for the patient's recovery. The case stands as a testament to the evolving landscape of cancer treatment, showcasing the potential of innovative medications like Polivy in combatting challenging diseases.


Source :
This Article/News is also avaliable in following categories : Lakecity Headlines , Paras Health
Your Comments ! Share Your Openion

You May Like